Scripps MD Anderson Cancer Center

https://www.Scripps.org/HemOncCME

 

Managing M0CRPC with Androgen Receptor Antagonists: Analysis of Top New Trials - PROSPER (Enzalutamide), SPARTAN (Apalutamide), and ARAMIS (Darolutamide)

716 views
June 11, 2019
0 Comments
Login to view comments. Click here to Login
Topics in Cancer